glucosylceramides into ceramides (23, 24) , acidic sphingomyelinase converts sphingomyelin into ceramides (25, 26) , and phospholipases convert phospholipids into free fatty acids and glycerol (27, 28) . Both Gaucher's disease, due to a deficiency in beta glucocerebrosidase, and Niemann Pick disease, due to a deficiency in acidic sphingomyelinase, leads to defects in the extracellular lipid membranes and abnormal permeability barrier function due to the impaired conversion of lipid precursors into ceramides (23, 26) . Walter Holleran and colleagues will discuss in greater detail the extracellular processing of sphingolipids in the stratum corneum in their review. Of note, disruption of the permeability barrier produces an increase in beta glucocerebrosidase activity and mRNA levels in the epidermis (29) . Similarly, disruption of the permeability barrier also increases acidic sphingomylinase activity in the epidermis (25) . Thus the activity of the two key enzymes that are required for the extracellular metabolism of lamellar body lipids to the lipid species that form the lamellar membranes is enhanced following permeability barrier disruption. Additionally, inhibition of PLA2 activity, which blocks the conversion of phospholipids to free fatty acids, also leads to defects in the structure of the extracellular lipid membranes and permeability barrier homeostasis (27, 28) . There are several different isoforms of PLA2 expressed in the epidermis and which specific isoforms are important for the extracellular catabolism of phospholipids to fatty acids in the stratum corneum remains to be determined (30, 31) . Finally the cholesterol sulfate in the stratum corneum is metabolized by the lamellar body derived enzyme, steroid sulfatase, to cholesterol (see the review by Peter Elias and colleagues for a detailed discussion of the important role of the steroid sulfatase mediated breakdown of cholesterol sulfate in regulating corneocyte desquamation) (32).
JLR: Does this extracellular processing of lipids have other important effects in addition to providing the lipids required for the formation of the extracellular lipid membranes that mediate permeability barrier function?
KF: Yes. In fact a number of key stratum corneum functions are derived in part from this extracellular processing of lipids. The glycerol that is formed by the breakdown of phospholipids by phospholipases plays a role in the stratum corneum as a water holding agent, which helps to keep the stratum corneum hydrated. Hydration is crucial for a by on June 13, 2008 www.jlr.org Downloaded from smooth and flexible skin, and changes in hydration status signal several downstream responses including epidermal DNA synthesis and catabolism of filaggrin into deiminated carboxylic acid metabolites (33-37).
The free fatty acids that are formed by phospholipid breakdown contribute to the acidification of the stratum corneum (38, 39). The pH of the outer stratum corneum and skin surface in humans and animals ranges from 5-5.5 (40) . This acidic environment is very important as it regulates the activity of many of the enzymes in the stratum corneum (40). For example the activity of both beta glucocerebrosidase and acidic sphingomyelinase are optimal at or below pH 5.5, which is very similar to the pH of the stratum corneum. Conversely, many of the proteases in the stratum corneum have a pH optimum of 7 or higher and therefore their activity is decreased at the usual stratum corneum pH of 5.5 . If the pH of the stratum corneum is increased, the activity of beta glucocerebrosidase and acidic sphingomyelinase is reduced and the extracellular processing of glucosylceramides and sphingomyelins to ceramides is impaired leading to abnormalities in the structure of the extracellular lipid membranes and decreased permeability barrier function (4, (41) (42) (43) . Furthermore, elevations in stratum corneum pH stimulate protease activity resulting in increased corneocyte desquamation (4, 41, 42) . In newborns the pH of the stratum corneum is increased which could explain the decreased permeability barrier homeostasis and epidermal fragility that is observed during the neonatal period (4) . Similarly, many cutaneous inflammatory disorders also are associated with increases in stratum corneum pH, which could adversely affect enzyme activity in the stratum corneum resulting in a decrease in permeability barrier function and stratum corneum integrity and cohesion (40) . Finally, the breakdown of cholesterol sulfate to cholesterol by the enzyme steriod sulfatase plays an important role in regulating desquamation (12, 13, 32) . Steroid sulfatase deficiency results in recessive X-linked ichthyosis, which will be discussed in detail in the review by Peter Elias and colleagues (12, 13, 32) . Additionally, cholesterol sulfate stimulates keratinocyte differentiation, adversely effects permeability barrier function, and inhibits cholesterol synthesis and HMG CoA reductase activity in keratinocytes (44) (45) (46) (47) (48) . (49) . Recent studies have shown that ABCA12, a member of the ABC family of transporters, is required for lamellar body formation (50, 51) . Mutations in ABCA12 result in the failure to form normal lamellar bodies and extracellular lipid membranes (50, 51) . Severe mutations in ABCA12 are associated with Harlequins ichthyosis, a disease that is often fatal in childhood, while milder partial loss of function mutations in ABCA12 are associated with a less severe phenotype of lamellar ichthyosis type 2 (these disorders will be discussed in greater detail in the review by Peter Elias and coworkers) (50) (51) (52) (53) (54) .
JLR: What regulates lamellar body secretion?
KF: Acute disruption of the permeability barrier by mechanical forces (i.e. sequential tape stripping), solvents (i.e. acetone), or detergents (i.e. SDS) initiates a homeostatic repair response that results in the rapid recovery of permeability barrier function (55, 56) .
The first step in this repair response is the rapid secretion (within minutes) of the contents of the lamellar bodies from the outer stratum granulosum cells, resulting in a marked decrease in the number of lamellar bodies in stratum granulosum cells (50-80% of preexisting lamellar bodies are secreted) (57) . Newly formed lamellar bodies begin to reappear in the stratum granulosum cells and accelerated secretion continues until permeability barrier function returns towards normal (57) . If one artificially restores permeability barrier function to normal by application of an impermeable membrane, one can inhibit the further secretion of lamellar bodies (57) . Immediately following barrier disruption the increased water movement through the compromised stratum corneum carries calcium outward towards the skin surface resulting in a reduction in the calcium concentration surrounding the stratum granulosum cells (60) (61) (62) . This change in calcium concentration appears to be the primary signal inducing lamellar body secretion. If one prevents the reduction in calcium levels by providing exogenous calcium, lamellar body secretion does not occur and permeability barrier repair is not initiated (60) (61) (62) . Conversely if one lowers the calcium surrounding the stratum granulosum cells without disrupting the permeability barrier by either iontophoresis or sonophoresis, lamellar body secretion is stimulated (63, 64) . It is likely that potassium and other ions also play a role in this signaling process (65) (66) (67) . In addition, other non-ionic signals generated in the stratum corneum and by keratinocytes may also influence the repair response (for review see (68) (87) (88) (89) . These observations demonstrate the importance of ELOVL4 in generating at least one of the lipids required for normal permeability barrier homeostasis. ELOV3 KO mice also have a defective permeability barrier and abnormalities in stratum corneum structure but since this enzyme is predominantly expressed in sebaceous glands and has only minimal expression in keratinocytes it is currently hypothesized that the defects in stratum corneum structure and function are secondary effects (90) .
JLR: Is desaturation of fatty acids important for permeability barrier homeostasis?
KF: The effects of permeability barrier disruption on the expression of enzymes that desaturate fatty acids have not been examined. Studies have shown that animals that are deficient in SCD2 (stearoyl-CoA desaturase 2) have a defective permeability barrier and many die soon after birth (91) . The barrier defect is associated with a decrease in lamellar body contents and a decrease in lamellar membranes in the stratum corneum (91) . In the SCD2 deficient mice the content of linoleic acid in the acylceramide fraction was markedly reduced with increased linoleic acid in phospholipids suggesting alterations in the partitioning of linoleic acid (91) . Given the important role of acylceramides in permeability barrier function the reduction of acylceramides containing linoleic acid could account for the observed barrier abnormalities. Of note is that approximately 30% of the animals survive and in these animals SCD1 appears to compensate for the absence of SCD2 (91) . However, in animals deficient in SCD1 (asebia mice) there are no abnormalities in permeability barrier homeostasis (SCD1 deficient mice have a sebaceous gland defect that will be discussed in Diane Thiboutot's review in this series) (92) . The absence of defects in permeability barrier function in asebia mice who have marked abnormalities in sebaceous glands and the presence of normal permeability barrier function in areas of human skin with a paucity of sebaceous glands indicates that the lipids produced by sebaceous glands are not essential for permeability barrier homeostasis (92, 93) . However, stratum corneum hydration is decreased in asebia mice who are deficient in sebaceous glands and in areas of human skin with a decreased number of sebaceous glands (92, 93) . The triglycerides in sebaceous lipids are metabolized by lipases to free fatty acids and glycerol and a decrease in glycerol in areas with reduced sebaceous gland activity leads to a decrease in stratum corneum hydration (92, 93) . (96, 98, 99) . The expression of brain, liver, and heart FABP is not usually detected in the epidermis (100, 101) . Acute disruption of the permeability barrier induces E-FABP expression and this increase can be prevented by covering with a vapor permeable membrane (102) . Additionally, inflammatory disorders including psoriasis are associated with increased E-FABP levels in the epidermis (95, 97, 98) . In animals deficient in E-FABP basal transepidermal water loss is lower than wild type animals indicating better barrier function (100, 101) . Following acute barrier disruption the return of barrier function to normal follows very similar kinetics as observed in wild type animals indicating that a deficiency in E-FABP does not markedly impair normal permeability barrier homeostasis (100, 101) . Of note though is that heart FABP is expressed in the epidermis of E-FABP knock out mice (usually not detectable in wild type mice) and it is possible that this increase in heart FABP compensates for the absence of E-FABP (100, 101).
JLR:
The fatty acids produced in the epidermis will serve as precursors for both phospholipids and ceramides. What is known about the synthesis of phospholipids in the epidermis? KF: Although phospholipids are essential constituents of lamellar bodies little is known about the regulation of the enzymes of phospholipid synthesis in the epidermis. Recent studies in our laboratory have focused on several of the enzymes involved in phospholipid synthesis (103) . AGPAT (1-acyl-sn-glycerol-3-phosphate acyltransferase) catalyzes the acylation of lysophosphatidic acid to form phosphatidic acid, the major precursor of all glycerolipids. The expression pattern of AGPAT isoforms is unique with relatively high constitutive expression of AGPAT 3, 4, and 5 but low constitutive expression of AGPAT 1 and 2 in murine epidermis (103) . Localization studies indicated that all five isoforms of AGPAT were expressed in all nucleated layers of the epidermis (103) . Moreover, acute permeability barrier disruption rapidly increased AGPAT 1, 2, and 3 mRNA levels and the increase was sustained for at least 24 hours (103) . In parallel with the increase in mRNA levels, an increase in AGPAT activity also occurred (103) .
Additionally, the increase in AGPAT expression could be partially reversed by artificial barrier restoration by occlusion with an impermeable membrane indicating that the expression of AGPATs is linked to permeability barrier requirements (103) . In contrast, mGPAT (mitochondrial sn-glycerol-3-phosphate acyltransferase) expression did not change after permeability barrier disruption (103) .
JLR: Are there other pathways of fatty acid metabolism that play a role in permeability barrier function?
KF: The LOX (lipoxygenase) pathway in the epidermis plays a role in epidermal differentiation and hence permeability barrier function (104) . Mutations in either 12R-LOX or eLOX-3 are associated with autosomal recessive congenital ichthyosis (these disorders will be discussed in detail in the review by Peter Elias) (105-107). Both 12R-LOX and eLOX-3 are localized to the differentiated stratum granulosum layer of the epidermis and convert arachidonic acid to hepoxilin-and trioxilin-like compounds that are believed to play a role in regulating keratinocyte differentiation (105, (108) (109) (110) (111) .
Moreover, very recent studies have shown that the creation of 12R-lipoxygenase deficient mice results in a severe impairment in barrier function with the mice dying soon after birth from a defective barrier (108) . Abnormalities were not observed in the extracellular lipid lamellar membranes that mediate barrier function and the levels of total fatty acids, cholesterol, and ceramides were not different than wild type mice (108) . However, in the protein bound ceramide fraction that is covalently bound to the cornified envelope, there were alterations in the distribution of ceramide species, which might account for the permeability barrier abnormality (108) . How metabolites of the LOX pathway are linked with epidermal differentiation and permeability barrier formation remains to be elucidated.
JLR: What is known about the role of permeability barrier function in regulating ceramide synthesis in the epidermis?
KF: Acute barrier disruption stimulates sphingolipid synthesis in the epidermis and this increase in synthesis occurs in both the lower and upper epidermal layers (112, 113) .
However, in contrast to cholesterol and fatty acid synthesis, the increase in sphingolipid synthesis is delayed first occurring 6 hours after barrier disruption (112) . Additionally, the activity and mRNA levels of serine palmitoyl transferase, the first enzyme in the sphingolipid pathway, increase following barrier disruption (80, 112, 113) . Occlusion with an impermeable membrane can inhibit the increase in sphingolipid synthesis and the increased expression of serine palmitoyl transferase demonstrating the link with permeability barrier function (112, 113) . Most importantly, the topical application of beta-chloro-L-alanine, an inhibitor of serine-palmitoyltransferase activity, slowed permeability barrier recovery at the late time points and reduced the number of lamellar bodies in stratum granulosum cells and sphingolipids in the stratum corneum (114). This inhibition was over-ridden by co-applications of ceramides indicating that the delay in repair was not due to non-specific toxicity of beta-chloro-L-alanine (114) . These studies demonstrate a key role for epidermal ceramide synthesis in latter phase of permeability barrier repair.
JLR: Are these ceramides modified?
KF: As noted earlier, glucosylceramides are the key ceramide constituent of lamellar bodies. Glucosylceramides are synthesized from ceramides by the enzyme, glucosylceramide synthase (UDP-glucose: ceramide glucosyltransferase). Under basal conditions, glucosylceramide synthase activity is localized predominantly in the outer epidermis (115, 116) . Surprisingly disruption of the permeability does not alter glucosylceramide synthase activity (115) . However, topical treatment with an inhibitor of glucosylceramide synthase activity, P4 (d, 1-threo-1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol), delays barrier recovery following acute disruption (115) . These results demonstrate that glucosylceramides are essential for permeability barrier homeostasis but that baseline epidermal glucosylceramide synthase activity appears sufficient to accommodate acute challenges to the barrier. Recent studies have confirmed the importance of glucosylceramide synthase for permeability barrier homeostasis. Mice with an epidermal specific deficiency of glucosylceramide synthase have marked abnormalities in permeability barrier function and die soon after birth (117) . Not unexpectedly they have abnormalities in both lamellar body and stratum corneum structure (117) .
JLR: Is triglyceride synthesis important for permeability barrier function?
KF: Triglycerides are synthesized in the epidermis but their role in permeability barrier homeostasis is poorly defined. DGAT2 is expressed in the epidermis while the expression of DGAT1 is barely detectable (118) . DGAT2 KO mice have abnormalities in permeability barrier function, which contributes to their demise soon after birth (118) .
The number of lamellar bodies is normal but the internal content of the lamellar bodies and the quantity of lamellar membranes in the extracellular space of the stratum corneum is greatly reduced (118) . However, it is unclear whether these abnormalities in cutaneous function are due to the absence of DGAT2 in the epidermis. When the skin of DGAT2 mice was transplanted to normal mice epidermal permeability barrier function normalized suggesting that the defects in permeability barrier function were not simply due to the absence of DGAT2 in the epidermis (118) . shown that psychological stress in both mice and humans results in impaired permeability barrier homeostasis (122) (123) (124) (125) . Studies have further shown that in psychologically stressed animals epidermal lipid synthesis is decreased leading to decreased lamellar body formation (126) . These abnormalities could be prevented by inhibiting either glucocorticoid action with RU 486 or glucocorticoid production with antalarmin, a CRH receptor antagonist (127) . Additionally, the abnormalities in permeability barrier homeostasis in psychologically stressed animals could be improved by treatment with topical lipids (126) .
JLR: Are the relative quantities of the key lipids important?
KF: It is clear that cholesterol, ceramides, and fatty acids are required for the formation of lamellar bodies in keratinocytes. When one topically applies a lipid mixture containing equimolar concentrations of all three essential lipids, permeability barrier recovery following acute disruption is normal (128) (129) (130) . In contrast, topical application of any one or two of the three key lipids to acutely perturbed skin actually results in a delay in permeability barrier repair associated with abnormal appearing lamellar bodies (128) (129) (130) . Both complete and incomplete mixtures of the three key lipids rapidly transverse the stratum corneum and are taken up by stratum granulosum cells thereby markedly altering the molar distribution of lipids leading to abnormalities in the formation of by on June 13, 2008 www.jlr.org Downloaded from lamellar bodies (128) (129) (130) . Along similar lines, chronic topical treatment with statins also results in abnormalities in lamellar body structure and permeability barrier homeostasis (57, 131) . However, this is not due to a deficiency in cholesterol content as cholesterol synthesis is normal due to the marked up-regulation of HMG CoA reductase (131) .
Rather fatty acid synthesis is also markedly stimulated, which leads to an excess of fatty acids that alters the structure of lamellar bodies (57, 131) . Thus, in order to synthesize lamellar bodies the key lipids must be present in appropriate distributions and an excess or deficiency of a particular lipid can disturb lamellar body formation.
JLR: Are extracutaneous derived lipids important for permeability barrier homeostasis?
KF: A number of lines of evidence suggest that extracutaneous lipids make a significant contribution to maintaining permeability barrier homeostasis. First, in the inhibitor experiments described above, despite a marked inhibition of lipid synthesis (for example topical statin treatment acutely inhibited cholesterol synthesis by greater than 90%), the inhibition of permeability barrier recovery is relatively modest (81, 85, 114) . This discrepancy suggests that alternative sources of lipid are available for the formation of lamellar bodies and the regeneration of stratum corneum lipid membranes. Second, studies in humans and animals have shown systemically administered labeled cholesterol and fatty acids are delivered to the epidermis (75, 83, 132, 133) . Third, essential fatty acids are present in the stratum corneum in large quantities and are required for the maintenance of a competent barrier (8) (9) (10) (11) . By definition these essential fatty acids are only obtained from dietary sources. Fourth, plant sterols, which are of dietary origin, are present on the skin surface (132, 134, 135) . Fifth, the epidermis lacks delta 6 and delta 5 desaturase activity and therefore must obtain arachidonic acid from extra epidermal sites (136, 137) . Sixth, plant derived fatty acids accumulate in the epidermis in certain disease states, such as Refsum's disease (138) . Lastly, studies have shown that adding glucosylceramides to the diet can improve permeability barrier function (139) . Taken together these observations indicate that extracutaneous sources contribute to the epidermal lipid pool but the precise contribution has not been determined.
JLR: Are lipoprotein receptors present on keratinocytes?
KF: Undifferentiated keratinocytes in culture have LDL receptors but with differentiation the LDL receptors are no longer present on the plasma membranes of keratinocytes (140) (141) (142) . In agreement with the in vitro studies, in vivo studies have demonstrated that LDL receptors are present only on the basal cells of normal murine and human epidermis i.e. undifferentiated cells (143, 144) . However, in hyperplastic disorders with associated permeability barrier abnormalities, such as essential fatty acid deficiency or psoriasis, LDL receptors are expressed in the more differentiated stratum spinosum and stratum granulosum (144) . Moreover, acute permeability barrier disruption induces an increase in LDL receptor mRNA and protein levels in the epidermis and this increase can be inhibited by occlusion with an impermeable membrane that restores permeability barrier function (76). In unpublished studies we have not observed a defect in permeability barrier homeostasis in LDL receptor knockout mice indicating that the LDL receptor is not essential for the formation and maintenance of a normal permeability barrier. The other lipoprotein receptor expressed in keratinocytes is SR-B1. SR-B1 is present in cultured human keratinocytes and calcium-induced differentiation markedly decreases SR-B1 levels (145) . SR-B1 mRNA is also expressed in murine epidermis and SR-B1 mRNA levels increase by 50% following acute barrier disruption (145) . Additionally, using immunofluorescence we demonstrated that SR-B1 is present in human epidermis predominantly in the basal layer and increases following barrier disruption (145) . The increase is completely blocked by occlusion with an impermeable membrane indicating that the increase in epidermal SR-B1 expression is regulated by permeability barrier requirements (145) . The precise role of SR-B1 in permeability barrier homeostasis remains to be determined. SR-B1 could facilitate the uptake of cholesterol from HDL particles.
JLR: Are the apolipoproteins that interact with lipoprotein receptors produced in the epidermis?
KF: The best studied is apolipoprotein E. Studies have shown that apolipoprotein E is synthesized by keratinocytes in culture and in vivo in the epidermis (76, 146, 147) . In fact human epidermal skin grafts transplanted onto mice results in the appearance of human by on June 13, 2008 www.jlr.org Downloaded from apolipoprotein E in the serum demonstrating that the production of apolipoprotein E in the skin may result in the systemic delivery of apolipoprotein E (148). The expression of apolipoprotein E in the epidermis is specified by a unique 1.0 kb enhancer domain located 1.7 kb downstream of the apolipoprotein E gene (149) . Deletion of this enhancer resulted in the lack of expression of apolipoprotein E in the epidermis. Epidermal apolipoprotein E mRNA levels are increased approximately 2 fold following acute disruption of the permeability barrier (76). In unpublished studies we have not noted any alteration in permeability barrier homeostasis in apolipoprotein E knock out mice. In addition to apolipoprotein E, studies have shown that apolipoprotein A-II and serum amyloid A, a protein that can associate with HDL, are made by epidermal cells (150, 151) . Of note is that apolipoprotein A-I is made by chicken and carp epidermis but does not appear to be made in mammalian epidermis (152, 153) . The role of these apolipoproteins in epidermal biology remains to be determined. One can speculate that KF: In cultured keratinocytes studies have shown that fatty acid uptake is mediated by a transport system that is temperature sensitive, has saturable kinetics, and is decreased by trypsin treatment (156, 157) . Additionally, fatty acid uptake in keratinocytes demonstrated a higher specificity for linoleic and arachidonic acid than for oleic acid indicating a preference for fatty acids that must be obtained from extra epidermal sources (157) . Recent studies by our and other laboratories have shown that FATP 1, 3, 4, and 6 (fatty acid transport protein) along with CD 36 (FAT-fatty acid transporter) are expressed in murine epidermis (158) (159) (160) . Following permeability barrier disruption there was an increase in FATP 1 and 6 and CD36 (158, 160) . Additionally, studies have shown that permeability barrier disruption increases CD36 mRNA levels and this increase can be blocked by occlusion with an impermeable membrane (158) . Of note is that mice with spontaneous mutations in FATP4 or certain targeted disruptions of FATP4 display a restrictive dermopathy and a markedly defective permeability barrier function, which leads to death soon after birth (161, 162) . Notably transgenic mice that overexpress FATP4 only in the epidermis can rescue mice with a spontaneous mutation in FATP4 (163) . This result together with the results seen with a targeted disruption of FATP4 indicate that it is the absence of FATP4 in the epidermis that causes the phenotypic changes and not alterations in fatty acid metabolism in other tissues. Additionally, studies in mice with a temporally controlled disruption of FATP4 in the epidermis have demonstrated a cutaneous phenotype with defective permeability barrier function but the phenotype was not anywhere near as severe as that seen in neonates (164) . The explanation for the milder phenotype in adult animals could be due to compensation by other FATPs. As noted above, studies have shown in adult mice that several FATPs are present in the epidermis including FATP 1, 3, 4, and 6 (160). However, studies of embryonic expression at day 18.5 revealed that FATP1 was not expressed in epidermis while the expression of FATP4 was relatively increased compared to the expression in adult epidermis (160) . Thus it is possible that newborn animals are more susceptible to the absence of FATP4 whereas in adult mice the other FATPs can partially compensate for the deficiency of FATP4. In contrast CD36 knockout mice and humans with a deficiency of CD36 do not have an apparent skin phenotype (165, 166) . These studies demonstrate the potentially important role of fatty acid transporters in the epidermis. These lipids do not enter the lamellar body secretory pathway but rather fill the extracellular spaces of the stratum corneum with hydrophobic non-lamellar lipid that inhibits the movement of water and electrolytes (184) . Treatment with these nonphysiological lipids can very rapidly, but only partially restore permeability barrier function towards normal (185) . A disadvantage of non-physiological lipids is that they also can inhibit the normal permeability barrier repair mechanisms and thus the underlying abnormality is not corrected (185) . The second approach is to use lipids or precursors of the lipids that are normally present in lamellar bodies. Studies have shown that appropriate molar mixes of lipids that contain cholesterol, ceramides, and fatty acids can improve permeability barrier homeostasis (128) (129) (130) . In contrast to non-physiologic lipids, these lipids are transported across the stratum corneum into the stratum granulosum cells where they mix with the endogenous pool of lipids (128) (129) (130) . Hence it is important that the appropriate mixture of lipid be used, because as noted above if incomplete or misbalanced mixtures of lipids are used, lamellar body contents are altered and permeability barrier homeostasis can be negatively impacted (128) (129) (130) 185 ).
In certain disease or developmental states, where a particular lipid class is decreased, a mixture of physiologic lipids in which the missing lipid is dominant is most beneficial.
For example in aged animals, where cholesterol synthesis is decreased to a greater degree than other lipid classes, studies have shown that topical treatment with cholesterol alone or cholesterol-dominant lipid mixtures improves permeability homeostasis while fatty acid dominant mixtures actually impede permeability barrier homeostasis (120) .
Similarly in atopic dermatitis a ceramide dominant mixture is beneficial (186) . One disadvantage of the use of physiological lipid mixtures is that in clinical conditions where by on June 13, 2008 www.jlr.org Downloaded from the lamellar body secretory system is malfunctioning (for example following UV or xirradiation or in very premature infants) physiological lipids cannot be incorporated into lamellar bodies, and therefore they cannot accelerate the movement of lipids to the extracellular spaces of the stratum corneum (26, (187) (188) (189) (190) . In some circumstances a mixture of physiologic and non-physiologic lipids may be ideal, because the action of physiologic lipids is delayed, while non-physiologic lipids, such as petrolatum, provide an immediate partial restoration of the barrier.
JLR: Dr Feingold any closing thoughts?
KF: So often in biology and medicine we focus on the harmful effects of lipids, such as atherosclerosis and obesity. However, with regards to the epidermis they provide the crucial ingredients that allow us to form a permeability barrier to the movement of water and electrolytes through the stratum corneum. While I have tried to discuss some of what is known about the role of lipids in the formation of this complex stratum corneum lamellar membrane that mediates permeability barrier function it should be obvious to the reader that much work remains to be done to fully understand the formation and regulation of the epidermal permeability barrier.
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